Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM-2008B study)

The Journal of Antimicrobial Chemotherapy
L PaganoF Aversa

Abstract

In order to assess physicians' compliance with international guidelines for the targeted treatment of invasive aspergillosis, 136 patients with acute myeloid leukaemia and proven/probable invasive aspergillosis were analysed. Compliance with Infectious Diseases Society of America (IDSA) and European Conference on Infections in Leukaemia (ECIL) guidelines was found to be relatively low (28% for ECIL and 55% for IDSA), although no significant differences were found between the two groups (adherence versus non-adherence). In both subgroup analyses (IDSA and ECIL), compliance with the guidelines did not impact the 120 day survival rate. Instead, adherence to guidelines led to a higher response rate to first-line antifungal treatment (76% in the IDSA group and 84% in the ECIL group). Guidelines establish categories of patients with homogeneous characteristics, and suggest optimal diagnostic and therapeutic options for them. Acquisition of good results through adherence to guidelines is confirmed by our series. Unfortunately, there are frequently reasons to deviate from these general recommendations, particularly in patients with acute myeloid leukaemia. Despite evidence-based recommendations, adherence to the guidelines does not con...Continue Reading

References

Apr 19, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D A StevensG A Pankey
Jan 13, 2001·International Journal of Technology Assessment in Health Care·F B Garfield, J M Garfield
Dec 4, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S AsciogluUNKNOWN Mycoses Study Group of the National Institute of Allergy and Infectious Diseases
Aug 9, 2002·The New England Journal of Medicine·Raoul HerbrechtUNKNOWN Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillu
Sep 19, 2003·Annals of Hematology·Angelika BöhmeUNKNOWN Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
Dec 4, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Johan MaertensUNKNOWN Caspofungin Salvage Aspergillosis Study Group
Apr 20, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Oliver A CornelyUNKNOWN AmBiLoad Trial Study Group
Aug 19, 2007·Transplant Infectious Disease : an Official Journal of the Transplantation Society·Ben E de Pauw, Robert H Rubin
Jan 8, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thomas J WalshUNKNOWN Infectious Diseases Society of America
Dec 17, 2008·International Journal of Antimicrobial Agents·Márcio Borges Sá, Rafael Zaragoza
Jan 6, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Konstantinos LeventakosDimitrios P Kontoyiannis

❮ Previous
Next ❯

Citations

Sep 13, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M MichalletP Vanhems
Sep 13, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·L DrgonaR Barnes
Nov 1, 2012·International Journal of Hematology·Mitsutoshi KurosawaTakashi Fukuhara
Feb 13, 2013·Clinical Drug Investigation·Rui BergantimJose Eduardo Guimarães
Nov 8, 2011·Médecine et maladies infectieuses·C Wintenberger
Oct 15, 2013·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·S Leroux, A J Ullmann
May 26, 2017·Current Opinion in Infectious Diseases·Elizabeth RobilottiStan Deresinski
Nov 30, 2011·Current Opinion in Infectious Diseases·Michelle R Ananda-RajahKarin T Thursky
Aug 7, 2020·The Journal of Infectious Diseases·Melissa D JohnsonDimitrios P Kontoyiannis
Jun 15, 2011·Current Opinion in Infectious Diseases·Victor E Mulanovich, Dimitrios P Kontoyiannis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
John W BaddleyPeter G Pappas
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Yasmine NivoixRaoul Herbrecht
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Arlo UptonKieren A Marr
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Thomas J WalshJ R Perfect
© 2021 Meta ULC. All rights reserved